US 12,390,645 B1
Spinal cord modulation for inhibiting pain via short pulse width waveforms, and associated systems and methods
Sangsoo Wesley Park, San Jose, CA (US)
Assigned to Nevro Corp., Redwood City, CA (US)
Filed by Nevro Corp., Redwood City, CA (US)
Filed on May 9, 2022, as Appl. No. 17/739,653.
Application 16/048,131 is a division of application No. 14/534,769, filed on Nov. 6, 2014, granted, now 10,149,978, issued on Dec. 11, 2018.
Application 17/739,653 is a continuation of application No. 16/781,960, filed on Feb. 4, 2020, abandoned.
Application 16/781,960 is a continuation of application No. 16/048,131, filed on Jul. 27, 2018, granted, now 10,569,089, issued on Feb. 25, 2020.
Claims priority of provisional application 61/901,255, filed on Nov. 7, 2013.
This patent is subject to a terminal disclaimer.
Int. Cl. A61N 1/36 (2006.01); A61N 1/05 (2006.01)
CPC A61N 1/36175 (2013.01) [A61N 1/36062 (2017.08); A61N 1/36157 (2013.01); A61N 1/36171 (2013.01); A61N 1/0553 (2013.01); A61N 1/36071 (2013.01)] 29 Claims
OG exemplary drawing
 
1. A method for reducing or eliminating pain in a patient, without causing paresthesia in the patient, the method comprising:
programming a computer-readable medium of an implantable signal generator to:
generate a non-paresthesia-producing therapy signal, wherein at least a portion of the therapy signal is at a frequency of from 2 Hz to 1,000 Hz, with a pulse width in a pulse width range from 10 microseconds to 50 microseconds, and a current amplitude in a current amplitude range from 0.5 mA to 20 mA; and
transmit the therapy signal to the dorsal column of the patient's spinal cord via a signal delivery device implanted in the patient's epidural space and electrically coupled to the implanted signal generator.